Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Hungary Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20113
20121
20132
20201
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed6
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab3
Hoffmann-La Roche2
Incyte Corporation2
Janssen Research & Development, LLC2
ADC Therapeutics S.A.1
CTI BioPharma1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse17
Lymphoma, Non-Hodgkin5
Lymphoma4
Recurrence4
Lymphoma, Follicular3
Neoplasms3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell2
Lymphoma, Mantle-Cell2
Waldenstrom Macroglobulinemia2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.